NO891260L - Fremgangsmaate for fremstilling av 4-aryl-4-piperidin (eller pyrrolidin eller hexahydroazepin) carbinoler. - Google Patents

Fremgangsmaate for fremstilling av 4-aryl-4-piperidin (eller pyrrolidin eller hexahydroazepin) carbinoler.

Info

Publication number
NO891260L
NO891260L NO89891260A NO891260A NO891260L NO 891260 L NO891260 L NO 891260L NO 89891260 A NO89891260 A NO 89891260A NO 891260 A NO891260 A NO 891260A NO 891260 L NO891260 L NO 891260L
Authority
NO
Norway
Prior art keywords
carbinols
aryl
hexahydroazepine
pyrrolidine
piperidine
Prior art date
Application number
NO89891260A
Other languages
English (en)
Other versions
NO891260D0 (no
Inventor
Engelbert Ciganek
Leonard Cook
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of NO891260D0 publication Critical patent/NO891260D0/no
Publication of NO891260L publication Critical patent/NO891260L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/04—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO89891260A 1988-03-28 1989-03-22 Fremgangsmaate for fremstilling av 4-aryl-4-piperidin (eller pyrrolidin eller hexahydroazepin) carbinoler. NO891260L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17435688A 1988-03-28 1988-03-28

Publications (2)

Publication Number Publication Date
NO891260D0 NO891260D0 (no) 1989-03-22
NO891260L true NO891260L (no) 1989-09-29

Family

ID=22635870

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89891260A NO891260L (no) 1988-03-28 1989-03-22 Fremgangsmaate for fremstilling av 4-aryl-4-piperidin (eller pyrrolidin eller hexahydroazepin) carbinoler.

Country Status (19)

Country Link
EP (1) EP0337167B1 (no)
JP (1) JP2907860B2 (no)
KR (1) KR0140891B1 (no)
AT (1) ATE109465T1 (no)
AU (1) AU623637B2 (no)
CA (1) CA1337418C (no)
DE (1) DE68917185T2 (no)
DK (1) DK145689A (no)
ES (1) ES2056990T3 (no)
FI (1) FI94240C (no)
HU (1) HU213671B (no)
IE (1) IE65811B1 (no)
IL (1) IL89746A0 (no)
MY (1) MY103990A (no)
NO (1) NO891260L (no)
NZ (1) NZ228479A (no)
PT (1) PT90127B (no)
RU (1) RU1836346C (no)
ZA (1) ZA892171B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ239023A (en) * 1990-07-24 1993-12-23 Merrell Dow Pharma N-substituted-hydroxyalkyl piperidine derivatives and pharmaceutical
DE4112353A1 (de) * 1991-04-16 1992-10-22 Basf Ag 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung
DE4215213A1 (de) * 1992-05-09 1993-11-11 Merck Patent Gmbh Arylacetamide
EP0666856B1 (en) * 1992-10-28 2000-01-05 MERCK SHARP & DOHME LTD. 4-arylmethyloxymethyl piperidines as tachykinin antagonists
US6656953B2 (en) 2000-12-06 2003-12-02 Sepracor Inc. 4,4-Disubstituted piperidines, and methods of use thereof
JP2005508956A (ja) * 2001-10-16 2005-04-07 エンドー ファーマシューティカルズ, インコーポレイティド 神経障害性機能不全の治療用のカルビノール
US20070249607A1 (en) 2006-04-17 2007-10-25 Bristol-Myers Squibb Company Nk-1 and serotonin transporter inhibitors
US8071778B2 (en) 2006-07-27 2011-12-06 Bristol-Myers Squibb Company Substituted heterocyclic ethers and their use in CNS disorders
US8026257B2 (en) 2007-07-11 2011-09-27 Bristol-Myers Squibb Company Substituted heterocyclic ethers and their use in CNS disorders
CN110520129A (zh) 2017-02-17 2019-11-29 特维娜有限公司 含有5元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
CN110446495B (zh) * 2017-02-17 2023-09-05 特维娜有限公司 含有7元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
CN116406268A (zh) 2020-10-27 2023-07-07 特维娜有限公司 δ-阿片样物质调节剂的结晶和无定形形式

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB888657A (en) * 1958-07-14 1962-01-31 J F Macfarlan & Co Ltd Piperidine carbinols
US3080372A (en) * 1960-03-25 1963-03-05 Res Lab Dr C Janssen 1-aroylalkyl-4-arylpiperidine derivatives
BE775611A (fr) * 1970-11-24 1972-03-16 Synthelabo Derives de la (diphenyl-3,3 propyl-1)-1 piperidine, leur preparation etles medicaments qui en contiennent
US4284635A (en) * 1978-11-29 1981-08-18 Eli Lilly And Company Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines
US4485109A (en) * 1982-05-07 1984-11-27 E. I. Du Pont De Nemours And Company 4-Aryl-4-piperidinecarbinols
JPS58213756A (ja) * 1982-05-07 1983-12-12 ザ・デュポン・メルク・ファーマシュウティカル・カンパニー 4−アリ−ル−4−ピペリジンカルビノ−ル類

Also Published As

Publication number Publication date
RU1836346C (ru) 1993-08-23
JP2907860B2 (ja) 1999-06-21
ATE109465T1 (de) 1994-08-15
MY103990A (en) 1993-10-30
DK145689D0 (da) 1989-03-22
ZA892171B (en) 1990-11-28
FI891473A0 (fi) 1989-03-28
NO891260D0 (no) 1989-03-22
DK145689A (da) 1989-09-29
CA1337418C (en) 1995-10-24
FI94240B (fi) 1995-04-28
AU623637B2 (en) 1992-05-21
EP0337167B1 (en) 1994-08-03
DE68917185T2 (de) 1995-01-05
JPH0249766A (ja) 1990-02-20
AU3171789A (en) 1989-09-28
HU213671B (en) 1997-09-29
KR0140891B1 (ko) 1998-06-01
IL89746A0 (en) 1989-09-28
PT90127B (pt) 1994-06-30
IE65811B1 (en) 1995-11-15
EP0337167A1 (en) 1989-10-18
PT90127A (pt) 1989-11-10
IE890913L (en) 1989-09-28
ES2056990T3 (es) 1994-10-16
FI891473L (fi) 1989-09-29
DE68917185D1 (de) 1994-09-08
HUT50787A (en) 1990-03-28
NZ228479A (en) 1991-12-23
KR890014475A (ko) 1989-10-23
FI94240C (fi) 1995-08-10

Similar Documents

Publication Publication Date Title
NO881697D0 (no) Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene.
DE58902481D1 (de) 1,3-disubstituierte pyrrolidine.
GR3022966T3 (en) Fluoro substituted benzocycloheptapyridine compounds, compositions and methods of use as antihistaminic compounds
NO891260D0 (no) Fremgangsmaate for fremstilling av 4-aryl-4-piperidin (eller pyrrolidin eller hexahydroazepin) carbinoler.
ATE144498T1 (de) Herstellung von substituierten piperidinen
AU8261787A (en) Medicaments for the treatment of depression
DK287D0 (da) Optisk rent s-(-)-1-propyl-2',6'-pipecoloxylidid- hydroklorid og fremgangsmaade til fremstilling der-af
NO944075D0 (no) Fremgangsmåte for fremstilling av (S)-3-amino-1-substituert pyrrolidiner
JPS6419066A (en) Dihydropyridineamides
DK379387D0 (da) Optisk rene 1,3-dioxenoner, fremgangsmaade til fremstilling deraf og anvendelse heraf
DE69012619D1 (de) Bis(1-Hydrocarbyloxy-2,2,6,6-tetramethylpiperidin-4-yl)-amin-derivate und stabilisierte Zusammensetzungen.
DE59007216D1 (de) Verfahren zur Herstellung von Clausenamid und Neoclausenamid und deren Derivate.
PT87563A (pt) Process for the preparation of vinylcephalosporins useful as medicaments
NZ228023A (en) 24(r)-scymnol; preparatory processes and pharmaceutical compositions
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
MX9203166A (es) 1-[(2-fluorofenil) (4-fluorofenil)fenilmetil]-ih-imidazol.
EP0021847A3 (en) Long acting sulfonamide injectable compositions
DE58902310D1 (de) Tetrahydropyridin-derivate.
DE69020783D1 (de) Stabilisierung von Wasserstoffsuperoxyd in Tests.
ATE81652T1 (de) 1,3-disubstituierte pyrrolidine.